USA TODAY International Edition

We may be ready for a booster shot, but who gets them, when is in flux

- Elizabeth Weise

In just a week, COVID- 19 vaccine boosters could begin to be available to all fully vaccinated Americans. But exactly who will be eligible and when won’t be decided until two key advisory committees meet days before the Biden administra­tion’s Sept. 20 start date.

That leaves little reaction time for health care administra­tors like Dr. Tammy Lundstrom, chief medical officer for Michigan- based Trinity Health, which operates 92 hospitals and 120 continuing care facilities in 22 states.

“We have our data team poised, ready to hit the button to help us identify all our patients who are ready for a booster,” Lundstrom said. “We’re anxiously waiting for guidance, as is everybody.”

Originally, President Joe Biden said a third shot booster dose for people with healthy immune systems would be offered beginning Sept. 20 to anyone who had gotten their second shot of either the Pfizer- BioNTech or Moderna vaccine at least eight months ago, pending authorizat­ion from the Food and Drug Administra­tion.

But the administra­tion walked that back over concerns the announceme­nt got ahead of recommenda­tions from the Food and Drug Administra­tion and Centers for Disease Control and Prevention advisory committees.

“The decision of which booster shots to give, when to start them and who will give them will be left completely to the scientists at the FDA and the Centers for Disease Control,” Biden said Thursday.

The FDA committee meets Friday to discuss booster recommenda­tions; the CDC committee meeting is not yet scheduled but could come the next day to meet the Sept. 20 goal.

The Vaccines and Related Biological Products Advisory Committee is where the FDA goes for outside advice on whether the data for drugs and vaccines shows they will be safe and effective. The committee also can grill the agency on questions it feels haven’t yet been answered. The CDC’s Advisory Committee on Immunizati­on Practices develops recommenda­tions for who should get vaccines and on what schedule.

Medical systems are preparing for a down- to- the- wire decision. “If you look back in in the history of the pandemic, most of the FDA decisions happened on a Friday and most of the CDC meetings happened on a Saturday or Sunday. So we’ve geared up,” Lundstrom said.

What those two committees say will determine who’s eligible for boosters and when, said Dr. Kelly Moore, president and chief executive officer of Immunize. org, which educates health care profession­als about U. S. vaccine recommenda­tions.

The White House initially said there would be an eight- month interval between the second and third dose, but it could be a “minimum” of six months with a “recommende­d” interval of eight months, Moore said. Decisions will depend on the data. “We can speculate all day long, but until we can see how these vaccines work in the real world, we don’t need to be speculatin­g about what our public policy should be,” she said.

As of Aug. 13, people with severely weakened immune systems, about 2.7% of the population, became eligible for a third shot after it was found they may not have gotten enough protection from the two- dose schedule.

It’s not known whether the CDC’s committee will simply recommend everyone get a booster after some specific number of months or will be more specific, such as saying health care workers or the elderly should go first.

“A specific interval would be easiest to implement,” Moore said.

At least initially, the only booster will be Pfizer- BioNTech’s, called Comirnaty, which was the first to submit data. Moderna‘ s applicatio­n to the FDA wasn’t completed until Sept. 3 and is still under review.

Supply is not expected to be a problem. COVID- 19 vaccines are plentiful and readily available in most of the United States at this point, so no one expects the availabili­ty challenges when the first vaccine doses were distribute­d in December and January.

It’s also easier to administer the Pfizer- BioNTech vaccine because its initial ultracold storage requiremen­ts have changed. Now it can be stored in an ordinary freezer for up to two weeks and then in an ordinary refrigerat­or for up to a month.

Still, much depends on the recommenda­tions for when to get a booster. Eight months ago, only about 2 million people had gotten their second dose of vaccine, almost all of them health care workers along with some seniors. Six months ago, the numbers were much higher and spread across a broader swath of America.

The one thing doctors are clear on is where to add the third shot to the CDC’s COVID- 19 Vaccinatio­n Record Card, Lundstrom said. The first two lines on the card are labeled “1st dose COVID- 19” and “2nd dose COVID- 19.” The last two lines are labeled “Other.”

“That’s where we’re asking people to document the third dose,” she said.

Health care systems are relying on the honor system for those who come in for boosters. No one’s going to have guards checking to see who’s eligible, said Rebecca Coyle, executive director of the American Immunizati­on Registry Associatio­n. However, the public should not push to the front of the line.

“Remember, any providers administer­ing these vaccines had to sign the provider enrollment agreement and is beholden to it,” she said.

Waiting longer is the better choice medically, said vaccinolog­ist, pharmacist and public health leader John Grabenstei­n. “You want multiple months to pass by so that your immune system matures and gets ready for that next dose,” he said.

Grabenstei­n said he hasn’t seen any data that shows people eight months out from their last shot have had significant loss of protection against severe disease.

“What matters is whether people continue to be protected against severe disease, not that people are protected against mild breakthrou­gh cases. The goal of the vaccinatio­n program is to prevent death.”

Newspapers in English

Newspapers from United States